カテゴリ： Allied Market Research, 世界, 医療/バイオ

ペット用糖尿病治療装置のグローバル市場（2021〜2031）：グルコース監視装置、インスリン送達装置

■ 英語タイトル：Pet Diabetes Care Devices Market By Device Type (Glucose monitoring devices, Insulin delivery devices), By Animal Type (Dogs, Cats), By End Users (Homecare, Veterinary hospitals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

調査会社Allied Market Research社が発行したリサーチレポート（データ管理コード：ALD23MA059）■ 発行会社/調査会社：Allied Market Research
■ 商品コード：ALD23MA059
■ 発行日：2022年12月
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：220
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Online Only（1名閲覧、印刷不可）USD3,570 ⇒換算￥542,640見積依頼/購入/質問フォーム
Single User（1名閲覧）USD5,730 ⇒換算￥870,960見積依頼/購入/質問フォーム
Enterprise User（閲覧人数無制限）USD9,600 ⇒換算￥1,459,200見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Allied Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[ペット用糖尿病治療装置のグローバル市場（2021〜2031）：グルコース監視装置、インスリン送達装置]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Allied Market Research社の本調査レポートによると、2021年に19億ドルであった世界のペット用糖尿病治療装置市場規模が、2031年までに35億ドルに達し、2022年から2031年の間に年平均6.3%で成長すると予測されています。本書は、ペット用糖尿病治療装置の世界市場について調査し、市場動向や今後の展望をまとめた資料です。イントロダクション、エグゼクティブサマリー、市場概要、装置別（グルコース監視装置、インスリン送達装置）分析、動物別（犬、猫）分析、エンドユーザー別（家庭、動物病院、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米・中東・アフリカ）分析、競争状況、企業情報など、以下の構成で掲載しています。本書内には、Allison Medical Inc.、ALR Technologies Inc.、Med Trust LLC、Zoetis、AccuBioTech Co., Ltd.、Merck & Co. Inc.、Becton, Dickinson and Company、Taidoc Technology Corp.、UltiMed, Inc、I-SENS. Inc.など、主な参入企業情報が含まれています。
・イントロダクション
・エグゼクティブサマリー
・市場概要
・世界のペット用糖尿病治療装置市場規模：装置別
- グルコース監視装置の市場規模
- インスリン送達装置の市場規模
・世界のペット用糖尿病治療装置市場規模：動物別
- 犬における市場規模
- 猫における市場規模
・世界のペット用糖尿病治療装置市場規模：エンドユーザー別
- 家庭における市場規模
- 動物病院における市場規模
- その他における市場規模
・世界のペット用糖尿病治療装置市場規模：地域別
- 北米のペット用糖尿病治療装置市場規模
- ヨーロッパのペット用糖尿病治療装置市場規模
- アジア太平洋のペット用糖尿病治療装置市場規模
- 中南米・中東・アフリカのペット用糖尿病治療装置市場規模
・競争状況
・企業情報

世界のペット用糖尿病治療装置市場は、2021年に19億ドルと評価され、2022年から2031年まで年平均成長率6.3%で成長して2031年には35億ドルに達すると予測されています。
糖尿病（diabetes mellitus）は、体内でブドウ糖を正常に利用できなくなることで発症する疾患です。ブドウ糖は体の細胞の主なエネルギー源です。犬や猫などのペットや家畜も糖尿病にかかります。肥満は、ペットの糖尿病発症の重要な危険因子であり、彼らはまた、犬の副腎の過活動や猫の甲状腺機能亢進症、膵炎、心臓病、腎臓病、尿路感染症や皮膚感染症など、糖尿病につながる可能性のある、または糖尿病の治療への反応に大きく影響することができる他の病気を発症する可能性があります。ペットのこの状態を治療するために、市場ではグルコースモニタリング装置とインスリンデリバリー装置に二分される装置セグメントが利用可能です。

ペット用糖尿病治療装置市場の成長は、糖尿病の罹患率の増加、動物病院における糖尿病モニタリング装置の需要の増加、ペット用糖尿病治療装置の技術進歩の増加などの要因によってもたらされます。さらに、人間のいくつかの利点のためのペットの採用の増加、世界中のペットの肥満のケースの増加、動物型医療に対する有利な政府の支援、ペットの所有者の間で獣医学的医療の重要性についての意識の成長、動物の医療費の増加、病院や動物医療センターの数の増加も市場の成長に役立ちます。例えば、米国ペット用品協会（APPA）のデータによると、2019年のペット支出は957億ドルに達し、2018年より5％増加しました。この支出には、ペットフード、おやつ、市販薬、獣医による治療、動物タイプの健康用品、その他のサービス（ボーディング、グルーミング、保険、トレーニング、ペットシッター、散歩を含む）が含まれます。しかし、ペットの糖尿病の適切な管理を取り巻く認識が限定的であることが、この市場の成長を妨げると予想されます。逆に、ペットの糖尿病に関する研究イニシアチブの増加は、市場に有利な機会を創出すると予想されます。

世界のペット用糖尿病治療装置市場は、装置タイプ、動物タイプ、エンドユーザー、地域によって区分されます。装置タイプ別では、市場はグルコースモニタリング装置とインスリンデリバリー装置に二分されます。動物タイプ別では、市場は犬と猫に分類されます。エンドユーザー別では、在宅医療、動物病院、その他に分類されます。地域別では、北米（米国、カナダ、メキシコ）、欧州（ドイツ、フランス、英国、イタリア、スペイン、その他の欧州）、アジア太平洋（日本、中国、オーストラリア、インド、韓国、その他のアジア太平洋）、LAMEA（ブラジル、南アフリカ、サウジアラビア、その他のLAMEA）に市場を分けて分析しています。

本レポートに掲載されている主要企業には、AccuBioTech Co., Ltd.、Allison Medical Inc.、ALR Technologies Inc.、Becton, Dickinson and Company、MED Trust、Merck Animal Health、TaiDoc、UltiMed, Inc.、Zoetis、i-SENS, Inc.などがあります。

〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までのペット用糖尿病治療装置市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、ペット用糖尿病治療装置の市場機会を特定します。
・主な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・ペット用糖尿病治療装置市場のセグメンテーションを詳細に分析し、市場機会を把握します。
・各地域の主要国を世界市場への収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・地域別および世界のペット用糖尿病治療装置市場動向、主要企業、市場セグメント、応用分野、市場成長戦略の分析を含みます。

〈主要市場セグメント〉
動物タイプ別
犬
猫

エンドユーザー別
在宅医療
動物病院
その他

装置タイプ別
グルコースモニタリング装置
インスリンデリバリー装置

地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
中国
日本
インド
オーストラリア
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域

〈主要市場プレイヤー〉
Allison Medical Inc.
ALR Technologies Inc.
Med Trust LLC
Zoetis
AccuBioTech Co., Ltd.
Merck & Co. Inc.
Becton, Dickinson and Company
Taidoc Technology Corp.
UltiMed, Inc
I-SENS. Inc.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Market dynamics
3.4.1.Drivers
3.4.1.1. Increase in the number of pet adoption.
3.4.1.2. Rise in the prevalence of diabetes in pets.
3.4.1.3. Rise in the pet obesity.
3.4.1.4. Increase in the research and development activity related to the treatment of diabetes.

3.4.2.Restraints
3.4.2.1. High cost of diabetic medications.

3.4.3.Opportunities
3.4.3.1. Technological advancements in the diabetes care devices.

3.5.COVID-19 Impact Analysis on the market
CHAPTER 4: PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE
4.1 Overview
4.1.1 Market size and forecast
4.2. Glucose monitoring devices
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market share analysis by country
4.3. Insulin delivery devices
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market share analysis by country
CHAPTER 5: PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE
5.1 Overview
5.1.1 Market size and forecast
5.2. Dogs
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market share analysis by country
5.3. Cats
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market share analysis by country
CHAPTER 6: PET DIABETES CARE DEVICES MARKET, BY END USERS
6.1 Overview
6.1.1 Market size and forecast
6.2. Homecare
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market share analysis by country
6.3. Veterinary hospitals
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market share analysis by country
6.4. Others
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market share analysis by country
CHAPTER 7: PET DIABETES CARE DEVICES MARKET, BY REGION
7.1 Overview
7.1.1 Market size and forecast
7.2 North America
7.2.1 Key trends and opportunities
7.2.2 North America Market size and forecast, by Device Type
7.2.3 North America Market size and forecast, by Animal Type
7.2.4 North America Market size and forecast, by End Users
7.2.5 North America Market size and forecast, by country
7.2.5.1 U.S.
7.2.5.1.1 Key market trends, growth factors and opportunities
7.2.5.1.2 Market size and forecast, by Device Type
7.2.5.1.3 Market size and forecast, by Animal Type
7.2.5.1.4 Market size and forecast, by End Users
7.2.5.2 Canada
7.2.5.2.1 Key market trends, growth factors and opportunities
7.2.5.2.2 Market size and forecast, by Device Type
7.2.5.2.3 Market size and forecast, by Animal Type
7.2.5.2.4 Market size and forecast, by End Users
7.2.5.3 Mexico
7.2.5.3.1 Key market trends, growth factors and opportunities
7.2.5.3.2 Market size and forecast, by Device Type
7.2.5.3.3 Market size and forecast, by Animal Type
7.2.5.3.4 Market size and forecast, by End Users
7.3 Europe
7.3.1 Key trends and opportunities
7.3.2 Europe Market size and forecast, by Device Type
7.3.3 Europe Market size and forecast, by Animal Type
7.3.4 Europe Market size and forecast, by End Users
7.3.5 Europe Market size and forecast, by country
7.3.5.1 Germany
7.3.5.1.1 Key market trends, growth factors and opportunities
7.3.5.1.2 Market size and forecast, by Device Type
7.3.5.1.3 Market size and forecast, by Animal Type
7.3.5.1.4 Market size and forecast, by End Users
7.3.5.2 France
7.3.5.2.1 Key market trends, growth factors and opportunities
7.3.5.2.2 Market size and forecast, by Device Type
7.3.5.2.3 Market size and forecast, by Animal Type
7.3.5.2.4 Market size and forecast, by End Users
7.3.5.3 UK
7.3.5.3.1 Key market trends, growth factors and opportunities
7.3.5.3.2 Market size and forecast, by Device Type
7.3.5.3.3 Market size and forecast, by Animal Type
7.3.5.3.4 Market size and forecast, by End Users
7.3.5.4 Italy
7.3.5.4.1 Key market trends, growth factors and opportunities
7.3.5.4.2 Market size and forecast, by Device Type
7.3.5.4.3 Market size and forecast, by Animal Type
7.3.5.4.4 Market size and forecast, by End Users
7.3.5.5 Spain
7.3.5.5.1 Key market trends, growth factors and opportunities
7.3.5.5.2 Market size and forecast, by Device Type
7.3.5.5.3 Market size and forecast, by Animal Type
7.3.5.5.4 Market size and forecast, by End Users
7.3.5.6 Rest of Europe
7.3.5.6.1 Key market trends, growth factors and opportunities
7.3.5.6.2 Market size and forecast, by Device Type
7.3.5.6.3 Market size and forecast, by Animal Type
7.3.5.6.4 Market size and forecast, by End Users
7.4 Asia-Pacific
7.4.1 Key trends and opportunities
7.4.2 Asia-Pacific Market size and forecast, by Device Type
7.4.3 Asia-Pacific Market size and forecast, by Animal Type
7.4.4 Asia-Pacific Market size and forecast, by End Users
7.4.5 Asia-Pacific Market size and forecast, by country
7.4.5.1 China
7.4.5.1.1 Key market trends, growth factors and opportunities
7.4.5.1.2 Market size and forecast, by Device Type
7.4.5.1.3 Market size and forecast, by Animal Type
7.4.5.1.4 Market size and forecast, by End Users
7.4.5.2 Japan
7.4.5.2.1 Key market trends, growth factors and opportunities
7.4.5.2.2 Market size and forecast, by Device Type
7.4.5.2.3 Market size and forecast, by Animal Type
7.4.5.2.4 Market size and forecast, by End Users
7.4.5.3 India
7.4.5.3.1 Key market trends, growth factors and opportunities
7.4.5.3.2 Market size and forecast, by Device Type
7.4.5.3.3 Market size and forecast, by Animal Type
7.4.5.3.4 Market size and forecast, by End Users
7.4.5.4 Australia
7.4.5.4.1 Key market trends, growth factors and opportunities
7.4.5.4.2 Market size and forecast, by Device Type
7.4.5.4.3 Market size and forecast, by Animal Type
7.4.5.4.4 Market size and forecast, by End Users
7.4.5.5 South Korea
7.4.5.5.1 Key market trends, growth factors and opportunities
7.4.5.5.2 Market size and forecast, by Device Type
7.4.5.5.3 Market size and forecast, by Animal Type
7.4.5.5.4 Market size and forecast, by End Users
7.4.5.6 Rest of Asia-Pacific
7.4.5.6.1 Key market trends, growth factors and opportunities
7.4.5.6.2 Market size and forecast, by Device Type
7.4.5.6.3 Market size and forecast, by Animal Type
7.4.5.6.4 Market size and forecast, by End Users
7.5 LAMEA
7.5.1 Key trends and opportunities
7.5.2 LAMEA Market size and forecast, by Device Type
7.5.3 LAMEA Market size and forecast, by Animal Type
7.5.4 LAMEA Market size and forecast, by End Users
7.5.5 LAMEA Market size and forecast, by country
7.5.5.1 Brazil
7.5.5.1.1 Key market trends, growth factors and opportunities
7.5.5.1.2 Market size and forecast, by Device Type
7.5.5.1.3 Market size and forecast, by Animal Type
7.5.5.1.4 Market size and forecast, by End Users
7.5.5.2 Saudi Arabia
7.5.5.2.1 Key market trends, growth factors and opportunities
7.5.5.2.2 Market size and forecast, by Device Type
7.5.5.2.3 Market size and forecast, by Animal Type
7.5.5.2.4 Market size and forecast, by End Users
7.5.5.3 South Africa
7.5.5.3.1 Key market trends, growth factors and opportunities
7.5.5.3.2 Market size and forecast, by Device Type
7.5.5.3.3 Market size and forecast, by Animal Type
7.5.5.3.4 Market size and forecast, by End Users
7.5.5.4 Rest of LAMEA
7.5.5.4.1 Key market trends, growth factors and opportunities
7.5.5.4.2 Market size and forecast, by Device Type
7.5.5.4.3 Market size and forecast, by Animal Type
7.5.5.4.4 Market size and forecast, by End Users
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1 Allison Medical Inc.
9.1.1 Company overview
9.1.2 Key Executives
9.1.3 Company snapshot
9.1.4 Operating business segments
9.1.5 Product portfolio
9.1.6 Business performance
9.1.7 Key strategic moves and developments
9.2 ALR Technologies Inc.
9.2.1 Company overview
9.2.2 Key Executives
9.2.3 Company snapshot
9.2.4 Operating business segments
9.2.5 Product portfolio
9.2.6 Business performance
9.2.7 Key strategic moves and developments
9.3 Med Trust LLC
9.3.1 Company overview
9.3.2 Key Executives
9.3.3 Company snapshot
9.3.4 Operating business segments
9.3.5 Product portfolio
9.3.6 Business performance
9.3.7 Key strategic moves and developments
9.4 Zoetis
9.4.1 Company overview
9.4.2 Key Executives
9.4.3 Company snapshot
9.4.4 Operating business segments
9.4.5 Product portfolio
9.4.6 Business performance
9.4.7 Key strategic moves and developments
9.5 AccuBioTech Co., Ltd.
9.5.1 Company overview
9.5.2 Key Executives
9.5.3 Company snapshot
9.5.4 Operating business segments
9.5.5 Product portfolio
9.5.6 Business performance
9.5.7 Key strategic moves and developments
9.6 Merck & Co. Inc.
9.6.1 Company overview
9.6.2 Key Executives
9.6.3 Company snapshot
9.6.4 Operating business segments
9.6.5 Product portfolio
9.6.6 Business performance
9.6.7 Key strategic moves and developments
9.7 Becton, Dickinson and Company
9.7.1 Company overview
9.7.2 Key Executives
9.7.3 Company snapshot
9.7.4 Operating business segments
9.7.5 Product portfolio
9.7.6 Business performance
9.7.7 Key strategic moves and developments
9.8 Taidoc Technology Corp.
9.8.1 Company overview
9.8.2 Key Executives
9.8.3 Company snapshot
9.8.4 Operating business segments
9.8.5 Product portfolio
9.8.6 Business performance
9.8.7 Key strategic moves and developments
9.9 UltiMed, Inc
9.9.1 Company overview
9.9.2 Key Executives
9.9.3 Company snapshot
9.9.4 Operating business segments
9.9.5 Product portfolio
9.9.6 Business performance
9.9.7 Key strategic moves and developments
9.10 I-SENS. Inc.
9.10.1 Company overview
9.10.2 Key Executives
9.10.3 Company snapshot
9.10.4 Operating business segments
9.10.5 Product portfolio
9.10.6 Business performance
9.10.7 Key strategic moves and developments

LIST OF TABLES
TABLE 1. GLOBAL PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 2. PET DIABETES CARE DEVICES MARKET FOR GLUCOSE MONITORING DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 3. PET DIABETES CARE DEVICES MARKET FOR INSULIN DELIVERY DEVICES, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 4. GLOBAL PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 5. PET DIABETES CARE DEVICES MARKET FOR DOGS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 6. PET DIABETES CARE DEVICES MARKET FOR CATS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 7. GLOBAL PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 8. PET DIABETES CARE DEVICES MARKET FOR HOMECARE, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 9. PET DIABETES CARE DEVICES MARKET FOR VETERINARY HOSPITALS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 10. PET DIABETES CARE DEVICES MARKET FOR OTHERS, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 11. PET DIABETES CARE DEVICES MARKET, BY REGION, 2021-2031 (REVENUE, $MILLION)
TABLE 12. NORTH AMERICA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 13. NORTH AMERICA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 14. NORTH AMERICA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 15. NORTH AMERICA PET DIABETES CARE DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 16. U.S. PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 17. U.S. PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 18. U.S. PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 19. CANADA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 20. CANADA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 21. CANADA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 22. MEXICO PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 23. MEXICO PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 24. MEXICO PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 25. EUROPE PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 26. EUROPE PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 27. EUROPE PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 28. EUROPE PET DIABETES CARE DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 29. GERMANY PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 30. GERMANY PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 31. GERMANY PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 32. FRANCE PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 33. FRANCE PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 34. FRANCE PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 35. UK PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 36. UK PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 37. UK PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 38. ITALY PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 39. ITALY PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 40. ITALY PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 41. SPAIN PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 42. SPAIN PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 43. SPAIN PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 44. REST OF EUROPE PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 45. REST OF EUROPE PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 46. REST OF EUROPE PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 47. ASIA-PACIFIC PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 48. ASIA-PACIFIC PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 49. ASIA-PACIFIC PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 50. ASIA-PACIFIC PET DIABETES CARE DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 51. CHINA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 52. CHINA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 53. CHINA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 54. JAPAN PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 55. JAPAN PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 56. JAPAN PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 57. INDIA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 58. INDIA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 59. INDIA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 60. AUSTRALIA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 61. AUSTRALIA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 62. AUSTRALIA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 63. SOUTH KOREA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 64. SOUTH KOREA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 65. SOUTH KOREA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 66. REST OF ASIA-PACIFIC PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 67. REST OF ASIA-PACIFIC PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 68. REST OF ASIA-PACIFIC PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 69. LAMEA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 70. LAMEA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 71. LAMEA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 72. LAMEA PET DIABETES CARE DEVICES MARKET, BY COUNTRY, 2021-2031 (REVENUE, $MILLION)
TABLE 73. BRAZIL PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 74. BRAZIL PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 75. BRAZIL PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 76. SAUDI ARABIA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 77. SAUDI ARABIA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 78. SAUDI ARABIA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 79. SOUTH AFRICA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 80. SOUTH AFRICA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 81. SOUTH AFRICA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 82. REST OF LAMEA PET DIABETES CARE DEVICES MARKET, BY DEVICE TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 83. REST OF LAMEA PET DIABETES CARE DEVICES MARKET, BY ANIMAL TYPE, 2021-2031 (REVENUE, $MILLION)
TABLE 84. REST OF LAMEA PET DIABETES CARE DEVICES MARKET, BY END USERS, 2021-2031 (REVENUE, $MILLION)
TABLE 85. ALLISON MEDICAL INC.: KEY EXECUTIVES
TABLE 86. ALLISON MEDICAL INC.: COMPANY SNAPSHOT
TABLE 87. ALLISON MEDICAL INC.: OPERATING SEGMENTS
TABLE 88. ALLISON MEDICAL INC.: PRODUCT PORTFOLIO
TABLE 89. ALLISON MEDICAL INC.: NET SALES
TABLE 90. ALLISON MEDICAL INC.: KEY STRATERGIES
TABLE 91. ALR TECHNOLOGIES INC.: KEY EXECUTIVES
TABLE 92. ALR TECHNOLOGIES INC.: COMPANY SNAPSHOT
TABLE 93. ALR TECHNOLOGIES INC.: OPERATING SEGMENTS
TABLE 94. ALR TECHNOLOGIES INC.: PRODUCT PORTFOLIO
TABLE 95. ALR TECHNOLOGIES INC.: NET SALES
TABLE 96. ALR TECHNOLOGIES INC.: KEY STRATERGIES
TABLE 97. MED TRUST LLC: KEY EXECUTIVES
TABLE 98. MED TRUST LLC: COMPANY SNAPSHOT
TABLE 99. MED TRUST LLC: OPERATING SEGMENTS
TABLE 100. MED TRUST LLC: PRODUCT PORTFOLIO
TABLE 101. MED TRUST LLC: NET SALES
TABLE 102. MED TRUST LLC: KEY STRATERGIES
TABLE 103. ZOETIS: KEY EXECUTIVES
TABLE 104. ZOETIS: COMPANY SNAPSHOT
TABLE 105. ZOETIS: OPERATING SEGMENTS
TABLE 106. ZOETIS: PRODUCT PORTFOLIO
TABLE 107. ZOETIS: NET SALES
TABLE 108. ZOETIS: KEY STRATERGIES
TABLE 109. ACCUBIOTECH CO., LTD.: KEY EXECUTIVES
TABLE 110. ACCUBIOTECH CO., LTD.: COMPANY SNAPSHOT
TABLE 111. ACCUBIOTECH CO., LTD.: OPERATING SEGMENTS
TABLE 112. ACCUBIOTECH CO., LTD.: PRODUCT PORTFOLIO
TABLE 113. ACCUBIOTECH CO., LTD.: NET SALES
TABLE 114. ACCUBIOTECH CO., LTD.: KEY STRATERGIES
TABLE 115. MERCK & CO. INC.: KEY EXECUTIVES
TABLE 116. MERCK & CO. INC.: COMPANY SNAPSHOT
TABLE 117. MERCK & CO. INC.: OPERATING SEGMENTS
TABLE 118. MERCK & CO. INC.: PRODUCT PORTFOLIO
TABLE 119. MERCK & CO. INC.: NET SALES
TABLE 120. MERCK & CO. INC.: KEY STRATERGIES
TABLE 121. BECTON, DICKINSON AND COMPANY: KEY EXECUTIVES
TABLE 122. BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
TABLE 123. BECTON, DICKINSON AND COMPANY: OPERATING SEGMENTS
TABLE 124. BECTON, DICKINSON AND COMPANY: PRODUCT PORTFOLIO
TABLE 125. BECTON, DICKINSON AND COMPANY: NET SALES
TABLE 126. BECTON, DICKINSON AND COMPANY: KEY STRATERGIES
TABLE 127. TAIDOC TECHNOLOGY CORP.: KEY EXECUTIVES
TABLE 128. TAIDOC TECHNOLOGY CORP.: COMPANY SNAPSHOT
TABLE 129. TAIDOC TECHNOLOGY CORP.: OPERATING SEGMENTS
TABLE 130. TAIDOC TECHNOLOGY CORP.: PRODUCT PORTFOLIO
TABLE 131. TAIDOC TECHNOLOGY CORP.: NET SALES
TABLE 132. TAIDOC TECHNOLOGY CORP.: KEY STRATERGIES
TABLE 133. ULTIMED, INC: KEY EXECUTIVES
TABLE 134. ULTIMED, INC: COMPANY SNAPSHOT
TABLE 135. ULTIMED, INC: OPERATING SEGMENTS
TABLE 136. ULTIMED, INC: PRODUCT PORTFOLIO
TABLE 137. ULTIMED, INC: NET SALES
TABLE 138. ULTIMED, INC: KEY STRATERGIES
TABLE 139. I-SENS. INC.: KEY EXECUTIVES
TABLE 140. I-SENS. INC.: COMPANY SNAPSHOT
TABLE 141. I-SENS. INC.: OPERATING SEGMENTS
TABLE 142. I-SENS. INC.: PRODUCT PORTFOLIO
TABLE 143. I-SENS. INC.: NET SALES
TABLE 144. I-SENS. INC.: KEY STRATERGIES

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 抗コクシジウム薬のグローバル市場（2021〜2031）：イオノフォア、合成薬
  • 血圧測定用カフのグローバル市場（2021～2031）：再利用可能型カフ、使い捨て型カフ
  • フォトトリートメント機器のグローバル市場（2021～2031）：インテンスパルスライト（IPL）、レーザー機器、LED機器
  • 治療薬物モニタリング（TDM）のグローバル市場（2021-2031）：消耗品、装置
  • 肥満外科療法のグローバル市場（2021-2031）：補助機器、埋め込み型機器、その他
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(ALD23MA059 )"ペット用糖尿病治療装置のグローバル市場（2021〜2031）：グルコース監視装置、インスリン送達装置" (英文：Pet Diabetes Care Devices Market By Device Type (Glucose monitoring devices, Insulin delivery devices), By Animal Type (Dogs, Cats), By End Users (Homecare, Veterinary hospitals, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031)はAllied Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。